Table 1 Demographics and clinical characteristics of 56 newly diagnosed AML patients in this study
Characteristics (n) | Survivin CD34+ expression, n (%) | CD34- expression, n (%) |
|---|---|---|
Sex | Â | Â |
Female (17) | 8 (47%) | 9 (53%) |
Male (39) | 23 (59%) | 16 (41%) |
P value | 0.342 | Â |
Age | Â | Â |
≤40 years old (30) | 19 (63%) | 11 (37%) |
>40Â years old (24) | 10 (42%) | 14 (58%) |
P value | 0.226 | Â |
FAB | Â | Â |
M0 (5) | 3 (60%) | 2 (40%) |
M1 (12) | 10 (83%) | 2 (17%) |
M2 (8) | 2 (25%) | 6 (75%) |
M5 (23) | 17 (74%) | 6 (26%) |
M7 (8) | 1 (13%) | 7 (87%) |
P value | 0.148 | Â |
Laboratory analysis (median) | Â | Â |
WBC (109/L) | 16.4 | 15.8 |
Platelet (109/L) | 87 | 106 |
Hemoglobin (g/dL) | 9.6 | 4.3 |
BM blast, % | 36 | 21 |
PB blast, % | 17 | 10 |
P value | 0.174 | Â |